SG10201900819SA - Simian adenovirus nucleic acid- and amino acid- sequences, vectors containing same, and uses thereof - Google Patents
Simian adenovirus nucleic acid- and amino acid- sequences, vectors containing same, and uses thereofInfo
- Publication number
- SG10201900819SA SG10201900819SA SG10201900819SA SG10201900819SA SG10201900819SA SG 10201900819S A SG10201900819S A SG 10201900819SA SG 10201900819S A SG10201900819S A SG 10201900819SA SG 10201900819S A SG10201900819S A SG 10201900819SA SG 10201900819S A SG10201900819S A SG 10201900819SA
- Authority
- SG
- Singapore
- Prior art keywords
- sequences
- isolated
- vectors containing
- amino acid
- nucleic acid
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SIMIAN ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF The present invention relates to novel adenovirus strains with an improved seroprevalence. In one aspect, the present invention relates to isolated polypeptides of adenoviral capsid proteins such as hexon, penton and fiber protein and fragments thereof and polynucleotides encoding the same. Also provided is a vector comprising the isolated polynucleotide according to the invention and adenoviruses comprising the isolated polynucleotides or polypeptides according to the invention and a pharmaceutical composition comprising said vector, adenovirus, polypeptide and/or polynucleotide. The invention also relates to the use of the isolated polynucleotides, the isolated polypeptides, the vector, the adenoviruses and/or the pharmaceutical composition for the therapy or prophylaxis of a disease. (No figure)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2009/000672 WO2010085984A1 (en) | 2009-02-02 | 2009-02-02 | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| US17262409P | 2009-04-24 | 2009-04-24 | |
| US17485209P | 2009-05-01 | 2009-05-01 | |
| US26634209P | 2009-12-03 | 2009-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201900819SA true SG10201900819SA (en) | 2019-03-28 |
Family
ID=62196817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201900819SA SG10201900819SA (en) | 2009-02-02 | 2010-02-02 | Simian adenovirus nucleic acid- and amino acid- sequences, vectors containing same, and uses thereof |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JP2018078894A (en) |
| CY (1) | CY1120652T1 (en) |
| DK (1) | DK2391638T3 (en) |
| ES (1) | ES2687294T3 (en) |
| HR (1) | HRP20181377T1 (en) |
| HU (1) | HUE039908T2 (en) |
| LT (1) | LT2391638T (en) |
| PT (1) | PT2391638T (en) |
| SG (1) | SG10201900819SA (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022007774A1 (en) * | 2020-07-06 | 2022-01-13 | 嘉兴安宇生物科技有限公司 | Novel chimpanzee adenovirus vector, construction method therefor, and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2375557T3 (en) * | 2001-06-22 | 2012-03-02 | The Trustees Of The University Of Pennsylvania | ADENOVIRUS RECOMBINANTS THAT UNDERSTAND PROTEIN OF ADEOVIRUS OF AIMS AND USES OF THE SAME. |
| HU230488B1 (en) * | 2001-11-21 | 2016-08-29 | The Trustees Of The University Of Pennsylvania | Simian adeniovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| CA2880060C (en) * | 2004-01-23 | 2018-03-13 | Agostino Cirillo | Chimpanzee adenovirus vaccine carriers |
| MX2011007980A (en) * | 2009-02-02 | 2011-08-17 | Okairos Ag | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof. |
-
2010
- 2010-02-02 SG SG10201900819SA patent/SG10201900819SA/en unknown
- 2010-02-02 HU HUE10702615A patent/HUE039908T2/en unknown
- 2010-02-02 DK DK10702615.5T patent/DK2391638T3/en active
- 2010-02-02 PT PT10702615T patent/PT2391638T/en unknown
- 2010-02-02 LT LTEP10702615.5T patent/LT2391638T/en unknown
- 2010-02-02 HR HRP20181377TT patent/HRP20181377T1/en unknown
- 2010-02-02 ES ES10702615T patent/ES2687294T3/en active Active
-
2017
- 2017-12-12 JP JP2017238046A patent/JP2018078894A/en active Pending
-
2018
- 2018-08-28 CY CY181100894T patent/CY1120652T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018078894A (en) | 2018-05-24 |
| DK2391638T3 (en) | 2018-08-27 |
| ES2687294T3 (en) | 2018-10-24 |
| HUE039908T2 (en) | 2019-02-28 |
| CY1120652T1 (en) | 2019-12-11 |
| PT2391638T (en) | 2018-10-19 |
| LT2391638T (en) | 2018-10-10 |
| HRP20181377T1 (en) | 2018-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011007980A (en) | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof. | |
| NZ603348A (en) | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| CL2019002280A1 (en) | Viral and adenoviral vectors and compositions based on a genetically modified human ornithine transcarbamylase (hotch) sequence and its use in the treatment of otc deficiency. (divisional request 201602235) | |
| WO2010138263A3 (en) | Novel aav 's and uses thereof | |
| WO2013036791A3 (en) | Modified adenoviral vectors and methods of treatment using same | |
| MX2020000221A (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof. | |
| PH12013500050A1 (en) | Anticancer fusion protein | |
| RU2016146664A (en) | ADENOVIRUS CONTAINING ALBUMINE-BINDING SITE | |
| WO2013040093A3 (en) | Glucagon-like peptide-2 compositions and methods of making and using same | |
| NZ708144A (en) | Recombinant adenoviruses and use thereof | |
| EP2470670A4 (en) | Coagulation factor vii compositions and methods of making and using same | |
| JP2017514483A5 (en) | ||
| IL201231A0 (en) | Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells | |
| JP2017534263A5 (en) | ||
| MX2011007307A (en) | Vector for treatment vaccine for stable and constitutive high-expression cervical cancer and recombinant lactobacillus transformed by the same. | |
| EP2589658A4 (en) | PARTICLE POLYPEPTIDE OF THE REIC / DKK-3 PROTEIN | |
| JP2008510493A5 (en) | ||
| TW200716750A (en) | Vaccine composition | |
| JP2014529399A5 (en) | ||
| NZ706884A (en) | Fc gamma receptor iib variants | |
| EP3844286A1 (en) | Recombinant replication competent viruses comprising a coding region for glycogen synthase kinase-3 (gsk3) and methods of killing aberrant cells | |
| Chroboczek et al. | Novel partner proteins of adenovirus penton | |
| SG10201900819SA (en) | Simian adenovirus nucleic acid- and amino acid- sequences, vectors containing same, and uses thereof | |
| Khatri et al. | Gene Expression by Atypical Recombinant Ovine Adenovirus Vectors during Abortive Infection of Human and Animal Cellsin Vitro | |
| Kim et al. | The effectiveness of the oncolytic activity induced by Ad5/F35 adenoviral vector is dependent on the cumulative cellular conditions of survival and autophagy |